Group 1 - The core point of the article is that MaiPu Medical announced a planned share reduction by a significant shareholder, which may impact the company's stock performance and investor sentiment [1] - GuoShou ChengDa (Shanghai) Health Industry Equity Investment Center plans to reduce its holdings by up to approximately 670,000 shares, representing 1% of the total share capital [1] - As of the announcement date, GuoShou ChengDa holds about 1.27 million shares, accounting for 1.8969% of the total share capital of MaiPu Medical [1] Group 2 - For the fiscal year 2024, MaiPu Medical's revenue composition is heavily weighted towards implantable medical devices, which account for 97.51% of total revenue [1] - The company's market capitalization is reported to be 4.6 billion yuan [1]
迈普医学：股东国寿成达拟减持不超过约67万股